Gilead Sciences (GILD) Revenue — Quarter Ended Jun 30, 2025
Revenue for the quarter rose both sequentially and compared to the same period last year.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue for the quarter rose both sequentially and compared to the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.1B
Revenue reported for this quarter.
Quarter-over-quarter
+6.2%
Change from the immediately preceding quarter.
Year-over-year
+1.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$28.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $7.5B | +7.0% |
| Dec 31, 2024 | $7.6B | +6.4% |
| Mar 31, 2025 | $6.7B | -0.3% |
| Jun 30, 2025 | $7.1B | +1.8% |
Revenue performance
The sequential increase reversed a decline from the prior quarter, while the year-over-year gain was modest.
Quarterly comparison
Compared with the immediately preceding quarter, revenue recovered. Against the same quarter one year earlier, revenue posted a positive change.
What to watch
Watch whether revenue can maintain its upward trajectory following recent quarterly fluctuations.